REPRODUCTIVE RIGHTS

Although these pharmacies dispensing the drug marks a victory for reproductive freedom, a looming Supreme Court case could cut off access to the medication in states where abortion is still legal.

Just weeks before Virginians go to the polls to elect the next General Assembly, Data for Progress has released new polling in the state’s most competitive legislative districts that illustrates voters’ lack of trust in Republicans on the issue of reproductive rights. The Nov. 7 General Assembly elections are the first state-level races in the…

The Republican presidential primary field is full of anti-abortion candidates, but amid massive electoral backlash to abortion bans, some candidates are attempting to backpedal or soften their stances on the campaign trail, or ignore the issue altogether.

A source familiar with the governor’s plans says that passing a 15-week abortion ban will be his legislative priority if Republicans win majority control of the state House and Senate in this fall’s elections.

Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication will likely become available at stores and online retailers in the U.S. in early 2024.

Women have suffered through ectopic pregnancies, miscarriages, fetal anomalies, and other complications, but have found it difficult to get the care they need due to restrictive abortion bans.

The 5th Circuit’s ruling maintains mifepristone’s availability for now, but severely limits access in ways that could harm patients seeking abortion care.

Access to the abortion medication mifepristone has been called into question following the issuance of competing rulings in Texas and Washington.

Erin Dinan, her husband Mike, and her son Petrus were at an appointment to find out the sex of their second child when her doctor told her the fetus had a very small chance of surviving post-birth. Dinan decided to have an abortion.